Reference number : 236-2018-2019-Q1-00692, amendment number : 1, agreement type : G, recipient legal name : Rossi, Carmine, recipient country : CA, recipient province : BC, recipient city : Vancouver, recipient postal code : V6T 1Z1, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : 143365, agreement value : 135000.0, agreement start date : 2018-06-01, agreement end date : 2019-03-14, description english : Population-level impact of direct-acting antiviral (DAA) therapies for chronic hepatitis C on extrahepatic manifestations, description french : Population-level impact of direct-acting antiviral (DAA) therapies for chronic hepatitis C on extrahepatic manifestations, expected results english : nan, expected results french : nan, additional information english : Amendment 1: Projected Agreement End Date., additional information french : Modification 1: Date de fin prévue de l'entente., owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada